BiotechTube
Home/Syntax Bio/Brad Merrill, PhD
BM

Brad Merrill, PhD

Cofounder, Head of Innovation

Syntax Bio

Therapeutic Areas

Type 1 Diabetes

Syntax Bio Pipeline

DrugIndicationPhase
Pancreatic Beta Cell TherapyType 1 DiabetesPreclinical

Leadership Team at Syntax Bio

JC
John Craighead, PhD
CEO
RC
Ryan Clarke, PhD
Cofounder, CTO
NB
Niko Balanis, PhD
Cofounder, VP Data Sci & Molecular Bio
NT
Nick Timmins, PhD
CSO
AM
Andy May, DPhil
Executive Chairman
View full Syntax Bio profile